Skip to main content
. 2022 Apr 9;11(4):571. doi: 10.3390/biology11040571

Table 2.

The Characteristics and Applications of BEs in Nonmodel Microbes.

Species Major Function Type Year gRNA Promoter Construct of Fusion Protein PAM Editing Window Editing Efficiency Multiplex Gene Editing Applications of BEs Off-Targets Refs
Industrially Important Microbes
Kluyveromyces marxianus Industrial production of various enzymes, chemicals, and macromolecules, as well as the utilization of cell biomass CBE 2017 PSNR52 PTSNR52 NGG −17 to −18 12.5–25% nr Inactivate Nej1 and Dnl4 to build NHEJ null mutants with an increased efficiency of homologous recombination and to facilitate multiple integration mediated by CRISPR/Cas9 nr [69]
Psedomonas spp. An excellent bacterial host to produce polymers, bulk chemicals, drugs, and high-price specialties CBE 2018 Ptrc PrpsL-rAPOBEC1-nCas9D10A NGG −13 to −18 100% nr Inactivate genes in P. aeruginosa PAO1, P. putida KT2440, P. fluorescens GcM5-1A, and P. syringae DC3000 to test editing window and efficiency nd in the six similar spacers of the rhlR and rhlB genes [41]
CBE 2020 Pj23119 Pbs/ParaBAD-rAPOBEC1-nCas9D10A na, none of the selected colonies achieved C-to-T mutations [70]
CBE 2020 Pj23119 Pbs-rAPOBEC1-eSpCas9ppD10A
CBE 2020 Pj23119 ParaBAD-rAPOBEC1-eSpCas9ppD10A NGG nr 20% nr Edit ttgA to test editing efficiency nr
CBE 2020 Pj23119 Pm-rAPOBEC1-eSpCas9ppD10A-UGI NGG −13 to −18 40–60% nr nr
CBE 2020 Pj23119 ParaBAD-rAPOBEC1-eSpCas9ppD10A-UGI NGG −13 to −18 80–100% 100% for double targets and 35% for triple targets Inactivate genes in P. putida, P. aeruginosa, P. fluorescens, and P. entomophila to prove CBE general availability; simultaneously edit genes by one-plasmid and two-plasmid system nd by Sanger sequencing the potential sites predicted by CasOT
CBE 2020 Pj23119 ParaBAD-rAPOBEC1-eSpCas9ppD10A-NG-UGI NG −13 to −18 100% 100% for double targets recognized by eSpCas9pp and eSpCas9-NG in a two-plasmid system Inactivate pykA and pcaH in one step; mutate G136 in AroF-2 to select a mutant strain with increased PCA titer up to 264.87 mg/L nr
CBE 2020 Pj23119 ParaBAD-YE1-eSpCas9ppD10A-UGI NGG −14 to −17 62.5% nr Precisely edit ttgA, which contains multiple cytidines with enhanced editing efficiency from 25% to 62.5% nr
Yarrowia lipolytica GRAS and industrial production of lipase and organic acids CBE 2019 PSCR1’-tRNAGly PUAS1B8-TEF(136)-nCas9D10A-PmCDA1-UGI NGG −14 to −20 28% 6.7% for double targets Inactivate TRP1, PEX10, HIS3 in ku70Δ strain to test editing efficiency nr [26]
CBE 2019 PSCR1’-tRNAGly PTEFin-nCas9D10A-PmCDA1-UGI NGG −14 to −20 94.3 ± 5% 31% for double targets nr
Streptomyces spp. Industrial production of bioactive secondary metabolites, such as antifungals, antivirals, antitumorals, anti-hypertensives, and mainly antibiotics, etc. CBE 2019 PermE* PtipA-rAPOBEC1-nCas9D10A-UGI NGG −11 to −17 30–100% 33.3% for triple targets Substitute amino acids in SCO5087 and SCO5092; inactivate genes of BGCs in nonmodel strain S. griseofuscus; efficiently and simultaneously inactivate two identical copies of kirN 38–56 by WGS (24–34 meaningful amino acid changes); whereas 29 SNVs in wild-type strain (18 amino acid changes); [44]
ABE 2019 PermE* PtipA-TadA-TadA*-nCas9D10A-UGI NGG −12 to −17 0–100% nr Target SCO5087 and a designed matrix containing NA motifs to test efficiency and preference 27–33 by WGS (20–21 meaningful amino acid changes)
CBE 2019 PkasO* PrpsL-rAPOBEC1-dCas9-UGI NGG −13 to −17 43–70% 43% for double targets Edit redD and actl to test C-to-T efficiency with a few C-to-G and C-to-A mutations nr [45]
CBE 2019 PkasO* PrpsL-rAPOBEC1-nCas9D10A-UGI NGG −13 to −17 100% 100% for double targets; 60% for quintuple targets Simultaneously disrupt the genes of polyketide synthase clusters to increase production of avermectin 3 by Sanger sequencing the sites predicted by CasOT;
CBE 2019 PkasO* PrpsL-rAPOBEC1-HF-nCas9D10A-UGI NGG −13 to −17 80% nr Edit olm to test off-target events, which was decreased to an undetectable level nd by Sanger sequencing the sites mentioned above
ABE 2019 PkasO* PrpsL-TadA-TadA*-dCas9 na, all selected colonies showed the A/G overlapping peak in sanger sequencing
ABE 2019 PkasO* PrpsL-TadA-TadA*-nCas9D10A NGG −14 to −17 100% nr Disrupt the initiation of actVB translation by converting ATG start codon to ACG to accumulate actinoperylone nr
CBE 2019 Pj23119 PermEp*-dCas9-PmCDA1-UL na, growth of cells is severely delayed when CBE was overexpressed by the strong constitutive promoter [46]
CBE 2019 Pj23119 PtipAp-dCas9-PmCDA1-UL NGG −16 to 20 10–100% 60% for double targets; 20% for triple targets Inactivate genes in S. coelicolor and S.rapamycinicus to test editing efficiency and general availability to other strains 1 by Sanger sequencing the potential sites predicted by Cas-OFFinder
CBE 2019 Pj23119 PtipAp-nCas9D10A-PmCDA1-UL NGG −16 to 20 15% nr Edit redW with low efficiency from C to T but 85% efficiency for C-to-G mutation nr
CBE 2021 Pgapdh (EL) PrpsL(XC)-rAPOBEC1-dCas9-UGI NGG −13 to −18 1–20% nr Edit redN, redD, and act_β-ketoacyl to test editing efficiency 16.50 ± 8.35 by WGS [71]
CBE 2021 Pgapdh (EL) PrpsL(XC)-rAPOBEC1-nCas9D10A-UGI NGG −13 to −18 3–25% nr nr
CBE 2021 Pgapdh (EL) PrpsL(XC)-rAPOBEC1-dCas9-UGI with asRNA NGG −13 to −18 21.2–65.8% nr 13.50 ± 3.32 by WGS
CBE 2021 Pgapdh (EL) PrpsL(XC)-rAPOBEC1-nCas9D10A-UGI with asRNA NGG −13 to −18 26.2–79.4% nr nr
Clostridium beijerinckii Production of acetone, n-butanol, isopropanol etc. CBE 2019 Pj23119 Pthl-rAPOBEC1-nCas9D10A-UGI NGG −13 to −17 20–100% nr Edit pyrE, xylR, spo0A, and araR to test efficiency of codon-optimized CBE; inactivate xylR to enhance the xylose fermentation nr [47]
Clostridium ljungdahlii Production of acetic acid and ethanol from waste gas CBE 2020 Pj23119 P2TetO1-dCas9-PmCDA1-UL NGG −11 to −19 2–55.6% nr Inactivate adhE1 and aor2 separately to increase acetate yield as well as lower ethanol production under either heterotrophic or autotrophic conditions nr [72]
Rhodobacter sphaeroides Industrial production of CoQ10, isoprenoids, poly-β-hydroxybutyrate, hydrogen CBE 2020 Pj23119 PLac-dCas9-PmCDA1-UL NGG −14 to 20 16.7% nr Inactivate appA and ppsR to test efficiency with pure C-to-T conversion nr [48]
CBE 2020 Pj23119 PLac-nCas9D10A-PmCDA1-UL NGG 14 to 20 10–96.7% 43% for double targets; 46.7% for triple targets Inactivate appA, etc., to test C-to-T efficiency with C-to-G and C-to-A byproducts; disrupt ubiF, ubiA, ubiG, and ubiX to reveal their importance in the CoQ10 biosynthetic pathway nr
ABE 2020 Pj23119 PLac-TadA-TadA*-dCas9 NGG −14 to −16 0–5% nr Edit appA, ppsR, crtB, and bchG to alter translation level or block translation initiation nr
ABE 2020 Pj23119 PLac-TadA-TadA*-nCas9D10A NGG −14 to −16 0–30% nr Edit appA, etc to alter translation level or block translation initiation nr
Shewanella oneidensis Bioelectricity production from biomass wastes CBE 2020 Ptac PrpsL-rAPOBEC1-nCas9D10A NGG −13 to −18 33.3–100% 87.5% for double targets Target NC motifs to test editing preference; inactivate gfp, blaA, and dmsE to test editing activity; identify key genes in GlcNAc or glucose metabolism to obtain a mutant strain with enhanced degradation efficiencies for organic pollutants nr [49]
Companilactobacillus crustorum Production of bacteriocin and 3-phenyllactic acid CBE 2021 P3 PsppA-rAPOBEC1-nCas9D10A NGG −14 to −18 75–100% nr Edit seven C-rich spacer sequences in a plasmid to test editing window and efficiency nr [73]
Agriculturally Important Microbes
Paenibacillus polymyxa Nitrogen fixation, plant growth promotion, soil phosphorus solubilization and production of cxopolysaccharides, hydrolytic enzymes, antibiotics, and cytokinin CBE 2021 Para Pgrac-nCas9D10A-PmCDA1 na, no transformant was obtained due to the toxicity of the fusion protein [56]
CBE 2021 Para Pspac-dCas9-PmCDA1-UGI NGG −16 to 20 100% 100% for double and triple targets; 83.3% for quadruple targets; 75.5% for quintuple targets Disrupt genes of five known BGCs to reveal the antimicrobial spectrum of the novel antibiotics in the sixth unknown BGCs 8.5 SNVs including 4.2 amino acid changes by WGS
Agrobacterium spp. Nature’s genetic engineer for diverse species including crops CBE 2021 Pj23119 PaadA-dCas9-PmCDA1-UGI-LVA na, no correct clones were obtained in E. coli probably due to the toxicity [74]
CBE 2021 Pj23119 PvirB-dCas9-PmCDA1-UL NGG −15 to −19 91% 80% for double targets Inactivate recA to maintain stability for plant transformation; separately inactivate rolB, rolC, and orf13 to confirm their importance in hair root construction nr
Sinorhizobium meliloti Perform symbiotic nitrogen fixation within leguminous host plants such as alfalfa, an important forage crop ABE 2021 PSigA/PRpoN/Ptyr PHemA-TadA-TadA*-nCas9D10A na, failed to mediate the A-to-G transition when gRNA is expressed by promoter SigA, RpoN or tyr [75]
ABE 2021 PRpsT PHemA-TadA-TadA*-nCas9D10A NGG −11 to −17 60% nr Edit nodA to test the editing efficiency nr
ABE 2021 PRpmJ PHemA-TadA-TadA*-nCas9D10A NGG −11 to −17 100% 90% for triple targets Edit nodA, nodB, nodC, nifD, nifH, and nifK to test if the promoters can drive the expression of the fusion protein to perform efficient editing nd by Sanger sequencing the potential sites predicted by Cas-OFFinder
ABE 2021 PRpmJ PNeo-TadA-TadA*-nCas9D10A NGG −11 to −17 100%
ABE 2021 PRpmJ PTau-TadA-TadA*-nCas9D10A NGG −11 to −17 80%
CBE 2021 PRpmJ PHemA-rAPOBEC1-nCas9D10A-UGI NGG −13 to −17 75% nr Inactivate nodA (W7*) to test if the growth of plants inoculated with the mutant strain was retarded
CBE 2021 PRpmJ PTau-rAPOBEC1-nCas9D10A-UGI NGG −13 to −17 100% nr
CBE 2021 PRpmJ PHemA-nCas9D10A-PmCDA1-UGI NGG −13 to −20 100% 80% for double targets; 50–70% for triple targets Edit nodA, etc to test editing efficiency
GBE 2021 PRpmJ PHemA-nCas9D10A-PmCDA1-UNG NGG −14 to −18 33–80% nr nr
Clinically Important Microbes
Brucella melitensis The most important agent of human brucellosis CBE 2018 PLlacO-1 Ptrc-rAPOBEC1-nCas9D10A-UGI-NLS NGG −15 100% nr Inactivate virB10 by targeting three sites with 100% editing efficiency at only one site nr [37]
Klebsiella pneumoniae Cause pneumonia, bloodstream infections, wound, or surgical site infections and meningitis; biosynthesize 1,3-propanediol and 2,3-butanediol CBE 2018 Pj23119 PrpsL-rAPOBEC1-nCas9D10A NGG −13 to −18 100% nr Edit fosA and dhaK to test editing efficiency with a few C-to-A byproducts; inactivate the blaKPC-2 and blaCTX-M-65 to dissect drug-resistance mechanisms nr [60]
Staphylococcus aureus Cause infections ranging from skin infections to severe systemic infections CBE 2018 Pcap 1A PrpsL-rAPOBEC1-nCas9D10A NGG −13 to −17 100% nr Inactivate agrA and cntA to test efficiency nr [76]
ABE 2020 Pcap 1A PrpsL-ecTadA-TadA*-nCas9D10A NGG −13 to −17 50–100% 100% for double targets Screen key residues of cntBC targeted by 38 gRNAs to obtain 42 mutant strains nd gRNA-dependent off-target by WGS [77]
Acinetobacter baumannii causing ventilator-associated pneumonia and bloodstream infections, and mortality rates can reach 35% CBE 2019 Pj23119 Ptac-rAPOBEC1-nCas9D10A NGG −13 to −18 20–100% nr Edit tynA, acel, adeB, cpdA, entE, and oxyR to test editing efficiency and preference of TC motifs; disrupt drug-resistance relevant genes blaOXA-23, blaTEM-1D, and blaADC-25 to dissect drug-resistance mechanisms nr [78]
Mycobacterium spp. Causes tuberculosis, getting 10 million infections and 1.45 million deaths in 2018 worldwide CBE 2021 Pj23119 PtetR-rAPOBEC1-dSt1Cas9 NNRGAA nr 4–15% nr Test availability of dSt1Cas9-BE in Mycobacterium with low efficiency for C-to-T but 18–70% efficiency for C-to-G nr [79]
CBE 2021 Pj23119 PtetR-rAPOBEC1-dSt1Cas9-UGI-UGI NNRGAA nr 12–95% nr Inactivate katG to obtain mutant strain with increasing resistance to Isoniazid treatment nr
CBE 2021 Pj23119 PtetR-rAPOBEC1-dSt1Cas9evolve-UGI-UGI NNNNAA −10 to −14 20–95% 87.5% for both double and triple targets Inactivate the essential L-leucine biosynthesis genes leuB and lueC; inactivate ctpE to increase bacterium aggregation in the presence of EGTA nd gRNA-dependent off-target by WGS
GBE 2021 Pj23119 PtetR-rAPOBEC1-dSt1Cas9-UNG NNRGAA nr 100% nr Edit five different loci to test editing efficiency nr
GBE 2021 Pj23119 PtetR-rAPOBEC1-dSt1Cas9evolve-UNG NNNNAA −13 to −16 20–65% 75% for triple targets Edit 29 endogenous genomics sites to find only TC motif is available for editing nr
CBE 2021 Pj23119 PtetO-rAPOBEC1-dSt1Cas9-UGI NNAGGAC nr 1.2% nr Inactivate gfp to test editing efficiency nr [80]
CBE 2021 Pj23119 PtetO-rAPOBEC1-nSt1Cas9-UGI NNAGGAC nr 10.3% nr nr
CBE 2021 Pj23119 PtetO-rAPOBEC1-nSt1Cas9-UGI with assistant plasmid expressing recX NNAGGAC −12 to −18 37.5–100% nr nr
CBE 2021 Pj23119 PtetO-rAPOBEC1-nSt1Cas9-UGI with assistant plasmid expressing recX and nucSE107A NNAGGAC nr 12.5–75% nr Inavtivate Rv0582, Rv0627 and Rv2530 to test efficiency; Inactivate katG to build a mutant stain with higher 50% minimum inhibitory concentration than the wild-type strain nr

nr: not reported, nd: not detected, na: not available, UL: UGI-LVA (protein degradation tag), SNVs: single-nucleotide variants, WGS: whole-genome sequencing, GRAS: generally recognized as safe, BGC: biosynthetic gene cluster. The construct of BEs that failed to work in microbes are marked in red.